Lupin completes its acquisition of GAVIS

09 Mar 2016 Evaluate

Lupin has completed its acquisition of privately held US based GAVIS Pharmaceuticals LLC and Novel Laboratories Inc. (GAVIS). The company had announced the acquisition on July 23rd 2015. The acquisition enhances the company’s scale in the US generic market and also broadens the company’s pipeline in dermatology, controlled substance products and other high-value and niche generics. GAVIS brings to the company a highly skilled US based Manufacturing & Research organization which would complement the company’s Coral Springs, Florida based R&D center for Inhalation. GAVIS’s New Jersey based manufacturing facility also becomes the company’s first manufacturing site in the US.

New Jersey based GAVIS is a privately held company specializing in formulation development, manufacturing, packaging, sales, marketing, and distribution of pharmaceuticals products. GAVIS has 62 ANDA filings pending approval with the US FDA and a pipeline of over 65+ products under development. 72% of these filings pending approvals represent niche dosage forms with 18 Para IVs and 8 FTFs products. GAVIS’s pending approvals address a market of over USD 9 billion.

The combined company will have a portfolio of over 120 in-market products, over 185 cumulative filings pending approval and a deep pipeline of products under development for the US. The acquisition creates the 5th largest pipeline of ANDA filings with the US FDA, addressing a USD 63.8 billion market. The company has 37 First-to-File (FTF) products which includes 17 exclusive FTF opportunities. The company and Gavis combined would now have over 45 FTFs. 

Lupin Share Price

2331.75 34.55 (1.50%)
24-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.80
Dr. Reddys Lab 1259.60
Cipla 1219.30
Zydus Lifesciences 886.50
Lupin 2331.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×